Skip to main content
Previous Poster Home Next

Utilization of Biomarker Testing and Biomarker-Driven Targeted Therapy Among Patientswith Metastatic Non-small Cell Lung Cancer
07:30am - 03:35pm EST - April 5, 2024

  • Information
  • Resources

Abstract: JNCCN23-0712 https://jnccn.org/view/journal...


Author(s):
  • Julie Wiedower Kaylor, PhDc, CGC, Guardant Health Inc.

Tags: Outcomes and Health Services Research

Display Label Action
Guardant NCCN Poster Draft 6.pdf Download Handout